AAAAAA
Results: 1-25/156
Authors:
KORNBLAU SM
ANDREEFF M
HU SX
XU HJ
PATEL S
THERIAULT A
KOLLER C
KANTARJIAN H
ESTEY E
DEISSEROTH AB
BENEDICT WF
Citation: Sm. Kornblau et al., LOW AND MAXIMALLY PHOSPHORYLATED LEVELS OF THE RETINOBLASTOMA PROTEINCONFER POOR-PROGNOSIS IN NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA -A PROSPECTIVE-STUDY, Clinical cancer research, 4(8), 1998, pp. 1955-1963
Authors:
DENG G
LANE C
KORNBLAU S
GOODACRE A
SNELL V
ANDREEFF M
DEISSEROTH AB
Citation: G. Deng et al., RATIO OF BCL-XSHORT TO BCL-XLONG IS DIFFERENT IN GOOD-PROGNOSIS AND POOR-PROGNOSIS SUBSETS OF ACUTE MYELOID-LEUKEMIA, Molecular medicine, 4(3), 1998, pp. 158-164
Authors:
WANG MWJ
CONSOLI U
LANE CM
DURETT A
LAUPPE MJ
CHAMPLIN R
ANDREEFF M
DEISSEROTH AB
Citation: Mwj. Wang et al., RESCUE FROM APOPTOSIS IN EARLY (CD34-SELECTED) VERSUS LATE (NON-CD34-SELECTED) HUMAN HEMATOPOIETIC-CELLS BY VERY LATE ANTIGEN 4-DEPENDENT AND VASCULAR CELL-ADHESION MOLECULE (VCAM) 1-DEPENDENT ADHESION TO BONE-MARROW STROMAL CELLS, Cell growth & differentiation, 9(2), 1998, pp. 105-112
Authors:
GUO XYD
CUILLEROT JM
WANG T
WU Y
ARLINGHAUS R
CLAXTON D
BACHIER C
GREENBERGER J
COLOMBOWALA I
DEISSEROTH AB
Citation: Xyd. Guo et al., PEPTIDE-CONTAINING THE BCR OLIGOMERIZATION DOMAIN (AA-1-160) REVERSESTHE TRANSFORMED PHENOTYPE OF P210(BCR-ABL) POSITIVE 32D MYELOID-LEUKEMIA CELLS, Oncogene, 17(7), 1998, pp. 825-833
Authors:
GARCIASANCHEZ F
PIZZORNO G
FU SQ
NANAKORN T
KRAUSE DS
LIANG J
ADAMS E
LEFFERT JJ
YIN LH
COOPERBERG MR
HANANIA E
WANG WL
WON JH
PENG XY
COTE R
BROWN R
BURTNESS B
GILES R
CRYSTAL R
DEISSEROTH AB
Citation: F. Garciasanchez et al., CYTOSINE DEAMINASE ADENOVIRAL VECTOR AND 5-FLUOROCYTOSINE SELECTIVELYREDUCE BREAST-CANCER CELLS 1 MILLION-FOLD WHEN THEY CONTAMINATE HEMATOPOIETIC-CELLS - A POTENTIAL PURGING METHOD FOR AUTOLOGOUS TRANSPLANTATION, Blood, 92(2), 1998, pp. 672-682
Authors:
RANDHAWA GS
CUI HM
BARLETTA JA
STRICHMANALMASHANU LZ
TALPAZ M
KANTARJIAN H
DEISSEROTH AB
CHAMPLIN RC
FEINBERG AP
Citation: Gs. Randhawa et al., LOSS OF IMPRINTING IN DISEASE PROGRESSION IN CHRONIC MYELOGENOUS LEUKEMIA, Blood, 91(9), 1998, pp. 3144-3147
Authors:
HU GY
LIU WB
MENDELSOHN J
ELLIS LM
RADINSKY R
ANDREEFF M
DEISSEROTH AB
Citation: Gy. Hu et al., EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND HUMAN-PAPILLOMAVIRUS E6 E7 PROTEINS IN CERVICAL-CARCINOMA CELLS/, Journal of the National Cancer Institute, 89(17), 1997, pp. 1271-1276
Authors:
DEISSEROTH AB
PIZZORNO G
Citation: Ab. Deisseroth et G. Pizzorno, THE USE OF CHEMOTHERAPY RESISTANCE IN CANCER-TREATMENT, The cancer journal from Scientific American, 3(2), 1997, pp. 60-69
Authors:
HENDERSON YC
GUO XYD
GREENBERGER J
DEISSEROTH AB
Citation: Yc. Henderson et al., POTENTIAL ROLE OF BCR-ABL IN THE ACTIVATION OF JAK1 KINASE, Clinical cancer research, 3(2), 1997, pp. 145-149
Authors:
SARRIS AH
DALIANI D
ULMER R
CROW M
BROXMEYER HE
REISS M
KARASAVVAS N
ZELENETZ AD
PUGH W
CABANILLAS F
DEISSEROTH AB
DUVIC M
Citation: Ah. Sarris et al., INTERFERON-INDUCIBLE PROTEIN-10 AS A POSSIBLE FACTOR IN THE PATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMAS, Clinical cancer research, 3(2), 1997, pp. 169-177
Authors:
HANANIA EG
DEISSEROTH AB
Citation: Eg. Hanania et Ab. Deisseroth, SIMULTANEOUS GENETIC CHEMOPROTECTION OF NORMAL MARROW-CELLS AND GENETIC CHEMOSENSITIZATION OF BREAST-CANCER CELLS IN A MOUSE CANCER GENE-THERAPY MODEL, Clinical cancer research, 3(2), 1997, pp. 281-286
Authors:
FU SQ
DEISSEROTH AB
Citation: Sq. Fu et Ab. Deisseroth, USE OF THE COSMID ADENOVIRAL VECTOR CLONING SYSTEM FOR THE IN-VITRO CONSTRUCTION OF RECOMBINANT ADENOVIRAL VECTORS, Human gene therapy, 8(11), 1997, pp. 1321-1330
Authors:
PRZEPIORKA D
ANDERLINI P
IPPOLITI C
KHOURI I
FIETZ T
THALL P
MEHRA R
GIRALT S
GAJEWSKI J
DEISSEROTH AB
CLEARY K
CHAMPLIN R
VANBESIEN K
ANDERSSON B
KORBLING M
Citation: D. Przepiorka et al., ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION IN ADVANCED HEMATOLOGIC CANCERS, Bone marrow transplantation, 19(5), 1997, pp. 455-460
Authors:
HANANIA EG
GILES RE
KAVANAGH J
FU SQ
ELLERSON D
ZU Z
WANG T
SU Y
KUDELKA A
RAHMAN Z
HOLMES F
HORTOBAGYI G
CLAXTON D
BACHIER C
THALL P
CHENG S
HESTER J
OSTROVE JM
BIRD RE
CHANG A
KORBLING M
SEONG D
COTE R
HOLZMAYER T
MECHETNER E
HEIMFELD S
BERENSON R
BURTNESS B
EDWARDS C
BAST B
ANDREEFF M
CHAMPLIN R
DEISSEROTH AB
Citation: Eg. Hanania et al., RESULTS OF MDR-1 VECTOR MODIFICATION TRIAL INDICATE THAT GRANULOCYTE MACROPHAGE COLONY-FORMING UNIT CELLS DO NOT CONTRIBUTE TO POSTTRANSPLANT HEMATOPOIETIC RECOVERY FOLLOWING INTENSIVE SYSTEMIC THERAPY (VOL 93, PG 15346, 1996)/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 5495-5495
Authors:
HENDERSON YC
CHOU M
DEISSEROTH AB
Citation: Yc. Henderson et al., INTERFERON REGULATORY FACTOR-1 INDUCES THE EXPRESSION OF THE INTERFERON-STIMULATED GENES, British Journal of Haematology, 96(3), 1997, pp. 566-575
Authors:
FU SQ
YIN LH
GARCIASANCHEZ F
DEISSEROTH AB
Citation: Sq. Fu et al., CORRELATION OF CELL-PROLIFERATION INHIBITION AND APOPTOSIS INDUCTION WITH EXPRESSION OF HUMAN BETA-5 INTEGRIN ON HEMATOPOIETIC-CELLS, Blood, 90(10), 1997, pp. 3494-3494
Authors:
DENG G
LANE C
KORNBLAU S
GOODACRE A
SNELL V
ANDREEFF M
DEISSEROTH AB
Citation: G. Deng et al., HIGHER LEVELS OF EXPRESSION OF BCL-2 AND BCL-XL IN POOR-PROGNOSIS (MONOSOMY-5 AND MONOSOMY-7) ACUTE MYELOID-LEUKEMIA (AML) CELLS THAN IN GOOD-PROGNOSIS (INVERSION-16 AND TRANSLOCATION-8-21)AML CELLS, Journal of investigative medicine, 44(3), 1996, pp. 214-214
Authors:
HENDERSON Y
DEISSEROTH AB
Citation: Y. Henderson et Ab. Deisseroth, A POTENTIAL MECHANISM FOR THE RESISTANCE OF INTERFERON-ALPHA TREATMENT IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS, Journal of investigative medicine, 44(3), 1996, pp. 232-232
Authors:
GUO XYD
HENDERSON YC
GREENBERGER J
DEISSEROTH AB
Citation: Xyd. Guo et al., ALTERED TYROSINE PHOSPHORYLATION OF JAK1 AND STAT1 PROTEINS IN 32D CELLS OVEREXPRESSING P210(BCR-ABL) ONCOPROTEIN, Journal of investigative medicine, 44(3), 1996, pp. 234-234
Authors:
BACHIER C
GILES RE
ELLERSON D
HANANIA EG
GARCIASANCHEZ F
HALEY T
CABANILLAS F
CHAMPLIN R
BERENSON R
HEIMFELD S
DEISSEROTH AB
Citation: C. Bachier et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH FOLLICULAR NON-HODGKINS-LYMPHOMAS (FNHL) USING CD34+ SELECTION AND RETROVIRAL HEMATOPOIETIC TRANSDUCTION, Journal of investigative medicine, 44(3), 1996, pp. 279-279
Authors:
HANANIA EG
GILES RE
KAVANAGH J
ELLERSON D
WANG T
ZU Z
CALVERT L
HALEY T
HAMER J
BERENSON R
HEIMFELD S
RAHMAN Z
CHAMPLIN R
DEISSEROTH AB
Citation: Eg. Hanania et al., THE HUMAN MULTIPLE-DRUG RESISTANCE GENE (MDR-1) IS USED TO CONFER CHEMOPROTECTION UPON HEMATOPOIETIC PROGENITOR CELLS IN A CLINICAL GENE-THERAPY TRIAL SETTING FOR OVARIAN AND BREAST-CANCER-TREATMENT, Journal of investigative medicine, 44(3), 1996, pp. 314-314
Authors:
ZHANG W
PIATYSZEK MA
KOBAYASHI T
ESTEY E
ANDREEFF M
DEISSEROTH AB
WRIGHT WE
SHAY JW
Citation: W. Zhang et al., TELOMERASE ACTIVITY IN HUMAN ACUTE MYELOGENOUS LEUKEMIA - INHIBITION OF TELOMERASE ACTIVITY BY DIFFERENTIATION-INDUCING AGENTS, Clinical cancer research, 2(5), 1996, pp. 799-803
Authors:
SEONG D
BRUNER JM
LEE KH
MIRZA N
KWON BD
LEE JH
LEE YY
RO J
TALPAZ M
CHAMPLIN R
DEISSEROTH AB
Citation: D. Seong et al., PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA, Clinical infectious diseases, 23(2), 1996, pp. 402-403
Authors:
DEISSEROTH AB
HOLMES F
HORTOBAGYI G
CHAMPLIN R
Citation: Ab. Deisseroth et al., USE OF SAFETY-MODIFIED RETROVIRUSES TO INTRODUCE CHEMOTHERAPY RESISTANCE SEQUENCES INTO NORMAL HEMATOPOIETIC-CELLS FOR CHEMOPROTECTION DURING THE THERAPY OF BREAST-CANCER - A PILOT TRIAL, Human gene therapy, 7(3), 1996, pp. 401-416
Authors:
FREEDMAN RS
PLASTOUCAS CD
DEISSEROTH AB
Citation: Rs. Freedman et al., USE OF A RETROVIRAL VECTOR TO STUDY THE TRAFFICKING PATTERNS OF PURIFIED OVARIAN TUMOR-INFILTRATING LYMPHOCYTES (TIL) USED IN INTRAPERITONEAL ADOPTIVE IMMUNOTHERAPY OF OVARIAN-CANCER PATIENTS - A PILOT-STUDY, Human gene therapy, 7(11), 1996, pp. 1351-1365